SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 59 filers reported holding AUTOLUS THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$201,000
-41.6%
48,250
-27.3%
0.00%
-55.6%
Q4 2021$344,000
-47.3%
66,327
-33.4%
0.01%
-25.0%
Q3 2021$653,000
+56.2%
99,650
+58.3%
0.01%
+50.0%
Q2 2021$418,00062,9500.01%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q3 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,300,000$17,160,0002.55%
Alphabet Inc. 699,352$9,231,0000.56%
DAFNA Capital Management LLC 100,000$1,320,0000.45%
JUPITER ASSET MANAGEMENT LTD 705,356$9,311,0000.29%
Artal Group S.A. 500,000$6,600,0000.26%
Cormorant Asset Management, LP 479,988$6,336,0000.25%
MPM BioImpact LLC 39,740$525,0000.19%
Granahan Investment Management 305,158$4,028,0000.18%
Burrage Capital Management LLC 13,113$173,0000.12%
Vident Investment Advisory, LLC 118,866$1,569,0000.10%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders